This study investigated the relative impact of personal stories and base rate evidence on the perceived risk of using two emerging recreational drugs: kratom and Spice. A 3 × 2 × 2 mixed-methods design was employed. Four hundred fifty-three young adults were randomly assigned to read internet postings that presented either 1) base rate information depicting the frequency of adverse reactions to Spice and kratom; 2) base rate information plus four personal web-postings describing beneficial reactions to Spice and kratom; or 3) base rate information plus four personal web-postings describing adverse reactions to Spice and kratom. Respondents subsequently evaluated the risk of using both drugs. Anecdotal evidence (personal stories) outweighed the impact of base rate evidence only when the personal stories described adverse drug reactions. Effective risk communication will benefit from differential use of both base rate evidence and personal stories.
AllenM.PreissR. W. (1997). Comparing the persuasiveness of narrative and statistical evidence using meta-analysis. Communication Research Reports, 14, 125-131.
Bar-HillelM. (1980). The base-rate fallacy in probability judgments. Acta Psychologica, 44, 211-233.
4.
BaumeisterR. F.BratslavskyE.FinkenauerC.VohsK. D. (2001). Bad is stronger than good. Review of General Psychology, 5, 323-370.
5.
BekkerH. L.WinterbottomA. E.ButowP.DillardA. J.Feldman-StewartD.FowlerF.J.Jibaja-WeissM.L.ShafferV.A.VolkR.J. (2013). Do personal stories make patient decision aids more effective? A critical review of theory and evidence. Medical Informatics and Decision Making, 13(Suppl. 2), Article S9.
6.
BetschC.HaaseN.RenkewitzF.SchmidP. (2015). The narrative bias revisited: What drives the biasing influence of narrative information on risk perceptions?Judgment and Decision Making, 10, 241-264.
7.
BetschC.UlshöferC.RenkewitzF.BetschT. (2011). The influence of narrative v. statistical information on perceiving vaccination risks. Medical Decision Making, 31, 742-753. doi:10.1177/0272989X11400419
8.
ChaikenS.TropeY. (1999). Dual-process theories in social psychology. New York, NY: Guilford Press.
9.
CorazzaO.ParrottA. C.DemetrovicsZ. (2017). Novel psychoactive substances: Shedding new lights on the ever-changing drug scenario and the associated health risks. Human Psychopharmacology: Clinical & Experimental, 32, Article e2616. doi:10.1002/hup.2616
10.
CoulsonC.CaulkinsJ. P. (2011). Scheduling of newly emerging drugs: A critical review of decisions over 40 years. Addiction, 107, 766-773. doi:10.1111/j.1360-0443.2011.03697.x
FagerlinA.Zikmund-FisherB. J.UbelP. A.JankovicA.DerryH. A.SmithD. M. (2007). Measuring numeracy without a math test: Development of the Subjective Numeracy Scale. Medical Decision Making, 27, 672-680.
13.
FerrerR.KleinW. M. (2015). Risk perceptions and health behavior. Current Opinion in Psychology, 1(5), 85-89.
14.
GreeneK.BrinnL. S. (2003). Messages influencing college women’s tanning bed use: Statistical versus narrative evidence format and a self-assessment to increase perceived susceptibility. Journal of Health Communication, 8, 443-461. doi:10.1080/713852118
15.
JohnsonL. A.JohnsonR. L.AlfonzoC. (2011). Spice: A legal marijuana equivalent. Military Medicine, 176, 718-720.
16.
JohnstonL. D.O’MalleyP. M.BachmanJ. G.SchulenbergJ. E. (2013a). Monitoring the Future national survey results on drug use, 1975-2012: Volume I, Secondary School Students. Ann Arbor: Institute for Social Research, The University of Michigan.
17.
JohnstonL. D.O’MalleyP. M.BachmanJ. G.SchulenbergJ. E. (2013b). Monitoring the Future national survey results on drug use, 1975-2012: Volume II, College students and adults ages 19-50. Ann Arbor: Institute for Social Research, The University of Michigan.
18.
KahnemanD. (2011). Thinking, fast and slow. New York, NY: Farrar, Straus and Giroux.
19.
LeiserowitzA. (2006). Climate change risk perception and policy preferences: The role of affect, imagery, and values. Climate Change, 77, 45-72.
20.
LipkusI. M.SamsaG.RimerB. K. (2001). General performance on a numeracy scale among highly educated samples. Medical Decision Making, 21, 37-44.
21.
MartinA.AnetteK. (2016). Aspects of substance displacement—From illicit drugs to novel psychoactive substances. Journal of Addiction Research & Therapy, 7, Article 283. doi:10.4172/2155-6105.1000283
22.
MounteneyJ.GriffithsP.SedefovR.NoorA.VicenteJ.SimonR. (2015). The drug situation in Europe: An overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015. Addiction, 111, 34-48.
23.
National Institute on Drug Abuse. (2018a). DrugFacts: Spice (“synthetic marijuana”). Bethesda, MD: National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services. Retrieved from http://www.drugabuse.gov/publications/drugfacts/spice-synthetic-marijuana
NetemeyerR.BurtonS.DelaneyB.HijjawiG. (2015). The legal high: Factors affecting young consumers’ risk perceptions and abuse of prescription drugs. Journal of Public Policy & Marketing, 34, 103-118. doi:10.1509/jppm.14.073
26.
PironaA.BoA.HedrichD.FerriM.van GelderN.GiraudonI.. . . MounteneyJ. (2017). New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe. International Journal of Drug Policy, 40, 84-92. doi:10.1016/j.drugpo.2016.10.004
27.
RozinP.BermanL.RoyzmanE. (2010). Biases in use of positive and negative words across twenty natural languages. Cognition and Emotion, 24, 536-548.
28.
RozinP.RoyzmanE. B. (2001). Negativity bias, negativity dominance, and contagion. Personality and Social Psychology Review, 5, 296-320.
29.
SheeranP.HarrisP. R.EptonT. (2014). Does heightening risk appraisals change people’s intentions and behavior? A meta-analysis of experimental studies. Psychological Bulletin, 140, 511-543. doi:10.1037/a0033065
30.
SlovicP.PetersE.FinucaneM. L.MacGregorD. G. (2005). Affect, risk, and decision making. Health Psychology, 24(4), S35-S40. doi:10.1037/0278-6133.24.4.S35
31.
SoJ.JeongS. H.HwangY. (2017). Which type of risk information to use for whom? Moderating role of outcome-relevant involvement in the effects of statistical and exemplified risk information on risk perceptions. Journal of Health Communication, 22, 304-311.
32.
SutherlandR.BrunoR.PeacockA.LentonS.MatthewsA.SalomC.. . . BarrattM. J. (2017). Motivations for new psychoactive substance use among regular psychostimulant users in Australia. International Journal of Drug Policy, 43, 23-32. doi:10.1016/j.drugpo.2016.12.021
33.
UbelP. A.JepsonC.BaronJ. (2001). The inclusion of patient testimonials in decision aids: Effects on treatment choices. Medical Decision Making, 21, 60-68.
34.
VosoughiS.RoyD.AralS. (2018). The spread of true and false news online. Science, 359, 1146-1151. doi:10.1126/science.aap9559
35.
WinterbottomA.BekkerH. L.ConnerM.MooneyA. (2008). Does narrative information bias individual’s decision making? A systematic review. Social Science & Medicine, 67, 2079-2088.
36.
ZimmermanU. S.WinkelmannP. R.PilhatschM.NeesJ. A.SpanagelR.ShulzK. (2009). Withdrawal phenomena and dependence syndrome after the consumption of “spice gold.”Deutsches Ärzteblatt International, 106, 464-467. doi:10.3238/arztebl.2009.0464
